163 related articles for article (PubMed ID: 37047565)
1. Engineering the Active Site Lid Dynamics to Improve the Catalytic Efficiency of Yeast Cytosine Deaminase.
Deng H; Qin M; Liu Z; Yang Y; Wang Y; Yao L
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047565
[TBL] [Abstract][Full Text] [Related]
2. Exploring Product Release from Yeast Cytosine Deaminase with Metadynamics.
Croney KA; McCarty J
J Phys Chem B; 2024 Apr; 128(13):3102-3112. PubMed ID: 38516924
[TBL] [Abstract][Full Text] [Related]
3. Role of glutamate 64 in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Wang J; Sklenak S; Liu A; Felczak K; Wu Y; Li Y; Yan H
Biochemistry; 2012 Jan; 51(1):475-86. PubMed ID: 22208667
[TBL] [Abstract][Full Text] [Related]
4. Product release mechanism and the complete enzyme catalysis cycle in yeast cytosine deaminase (yCD): A computational study.
Zhao Y; She N; Zhang X; Wang C; Mo Y
Biochim Biophys Acta Proteins Proteom; 2017 Aug; 1865(8):1020-1029. PubMed ID: 28478051
[TBL] [Abstract][Full Text] [Related]
5. Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Yao L; Li Y; Wu Y; Liu A; Yan H
Biochemistry; 2005 Apr; 44(15):5940-7. PubMed ID: 15823054
[TBL] [Abstract][Full Text] [Related]
6. Combined QM(DFT)/MM molecular dynamics simulations of the deamination of cytosine by yeast cytosine deaminase (yCD).
Zhang X; Zhao Y; Yan H; Cao Z; Mo Y
J Comput Chem; 2016 May; 37(13):1163-74. PubMed ID: 26813441
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of a transition-state analogue at the active site of yeast cytosine deaminase: importance of proton transfers.
Xu Q; Guo H; Gorin A; Guo H
J Phys Chem B; 2007 Jun; 111(23):6501-6. PubMed ID: 17506543
[TBL] [Abstract][Full Text] [Related]
8. A molecular dynamics exploration of the catalytic mechanism of yeast cytosine deaminase.
Yao L; Sklenak S; Yan H; Cukier RI
J Phys Chem B; 2005 Apr; 109(15):7500-10. PubMed ID: 16851861
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
10. Catalytic mechanism of yeast cytosine deaminase: an ONIOM computational study.
Sklenak S; Yao L; Cukier RI; Yan H
J Am Chem Soc; 2004 Nov; 126(45):14879-89. PubMed ID: 15535715
[TBL] [Abstract][Full Text] [Related]
11. A molecular dynamics study of the ligand release path in yeast cytosine deaminase.
Yao L; Yan H; Cukier RI
Biophys J; 2007 Apr; 92(7):2301-10. PubMed ID: 17218460
[TBL] [Abstract][Full Text] [Related]
12. Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine.
Lee H; Ryu J; Kim KA; Lee KS; Lee JY; Park JB; Park J; Choi SY
Exp Mol Med; 2004 Feb; 36(1):43-51. PubMed ID: 15031670
[TBL] [Abstract][Full Text] [Related]
13. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
[TBL] [Abstract][Full Text] [Related]
14. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
[TBL] [Abstract][Full Text] [Related]
15. Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay.
Christensen CL; Gjetting T; Poulsen TT; Cramer F; Roth JA; Poulsen HS
Clin Cancer Res; 2010 Apr; 16(8):2308-19. PubMed ID: 20371678
[TBL] [Abstract][Full Text] [Related]
16. Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Zamboni S; Mallano A; Flego M; Ascione A; Dupuis ML; Gellini M; Barca S; Cianfriglia M
Int J Oncol; 2008 Jun; 32(6):1245-51. PubMed ID: 18497986
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution.
Ko TP; Lin JJ; Hu CY; Hsu YH; Wang AH; Liaw SH
J Biol Chem; 2003 May; 278(21):19111-7. PubMed ID: 12637534
[TBL] [Abstract][Full Text] [Related]
18. PEGylation of yeast cytosine deaminase for pretargeting.
Xiong MP; Kwon GS
J Pharm Sci; 2005 Jun; 94(6):1249-58. PubMed ID: 15858841
[TBL] [Abstract][Full Text] [Related]
19. Computational Design of a Photocontrolled Cytosine Deaminase.
Blacklock KM; Yachnin BJ; Woolley GA; Khare SD
J Am Chem Soc; 2018 Jan; 140(1):14-17. PubMed ID: 29251923
[TBL] [Abstract][Full Text] [Related]
20. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer.
Nyati MK; Sreekumar A; Li S; Zhang M; Rynkiewicz SD; Chinnaiyan AM; Rehemtulla A; Lawrence TS
Cancer Res; 2002 Apr; 62(8):2337-42. PubMed ID: 11956093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
